Financial News · Live Terminal

Page 287 of 352

Market Chatter: Regeneron Reaches Drug Pricing Deal, Gains US Nod for Rare Deafness Therapy

Regeneron Pharmaceuticals (REGN) has struck an agreement with the Trump administration to reduce drug costs for certain Americans and has secured approval for a gene therapy to treat a rare form of deafness, Bloomberg reported on Thursday, citing a person familiar with the matter.Regeneron was the last company asked by Trump to align US costs with those in other developed countries under a most favored nations policy.The administration has pressured major pharmaceutical firms to sign pricing agreements to offer discounted prices or align costs with international markets, in exchange for incentives such as tariff exemptions.According to the report, the Food and Drug Administration is expected to authorize the treatment for an ultra-rare inherited hearing-loss condition caused by a genetic mutation.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $763.89, Change: $+17.31, Percent Change: +2.32%

$REGN

Wire63d ago

Rogers Communications' CapEx Cuts to Drive Organic De-levering, RBC Capital Markets Says

Rogers Communications' (RCI) capital expenditure reduction continues to support organic de-levering, which management targets to improve by 40 to 50 basis points over the next four years, RBC Capital Markets said in a note Tuesday.The company lowered its 2026 capex guidance to between 2.5 billion Canadian dollars ($1.83 billion) and CA$2.7 billion, from CA$3.3 billion to CA$3.5 billion previously, pushing free cash flow guidance higher to between CA$4.1 billion and CA$4.3 billion, from CA$3.3 billion to CA$3.5 billion, the brokerage said.RBC said Rogers Communications' management intended to allocate the incremental annual free cash flow of about CA$800 million to debt repayment. The investment firm also noted that the capex cuts are planned to be sustained as the company moves to prioritize critical investments across its networks.RBC Capital Markets raised its price target on Rogers Communications to CA$63 from CA$61, with an outperform rating.Price: $36.96, Change: $-0.52, Percent Change: -1.39%

$RCI

Wire63d ago

IBM Sees 'Solid' Start to 2026 With Q1 Topline Outperformance Coming From Infrastructure, RBC Says

IBM (IBM) saw a "solid" start to the year overall with topline outperformance in Q1 coming from its infrastructure segment, while consulting was in-line with consensus, RBC Capital Markets said in a Wednesday research note.IBM's software segment will be the main driver of 2026 revenue, aided by the company's Confluent acquisition closing about 2 months early, which RBC estimated equates to about $200 million.The company remains on track for an additional $1 billion in productivity savings in 2026, the analysts said, adding that IBM's AI-based software development system "Bob" and advancements in quantum development are key areas to watch throughout the year.IBM's expectation to add about $1 billion in free cash flow in 2026 could prove to be conservative given the company's strong start and ongoing cost saving initiatives, RBC added.RBC maintained its outperform rating with a $330 price target.Price: $229.44, Change: $-22.42, Percent Change: -8.90%

$IBM

Wire63d ago

Elevance Health's Tone on 2027 Commercial Pipeline 'Constructive,' RBC Says

Elevance Health's (ELV) tone on the 2027 commercial pipeline was "constructive," RBC Capital Markets said in a note emailed Thursday.Analysts said that the company's Q1 core performance beat expectations, supported by favorable Medicare claims experience, a better-than-anticipated adjusted operating expense ratio, and early traction with Medicaid cost actions.RBC said it is still cautious on the stock as Elevance navigates an elevated Medicaid cost environment, ongoing Affordable Care Act risk-pool uncertainty, and 2027 Medicare Advantage rates, which continue to fall behind trend.Analysts lowered their Q2 adjusted earnings per share estimate for the company to $6.14 from $6.64. Analysts polled by FactSet expect $6.38.RBC, however, increased the full-year 2026 adjusted earnings per share estimate to $26.82 from $25.55. Analysts surveyed by FactSet expect $26.43.Analysts maintained a sector perform rating on the stock and a $358 price target.Price: $343.85, Change: $+15.65, Percent Change: +4.77%

$ELV

Wire63d ago

Westamerica Bancorporation Ups Quarterly Dividend to $0.48 per Share from $0.46, Payable May 15 to Holders of Record May 4

$WABC

Wire63d ago

Lam Research Likely to Benefit from Healthy Wafer Fabrication Equipment Landscape, RBC Says

Lam Research (LRCX) is likely to benefit from healthy wafer fabrication equipment environment for the next two to three years driven by generative AI demand and memory tightness, RBC Capital Markets said in a Wednesday research report.The brokerage said it raised its fiscal 2026 and 2027 EPS guidance to $5.65 and $7.72, respectively, from $5.30 and $6.84 earlier.The company's fiscal Q3 beat was particularly driven by strength in DRAM and improving NAND outlook amid continued momentum in high bandwidth memory, analysts wrote.China exposure declined during the quarter, and the company expects further declines as global spending accelerates, but overall, China demand remains steady, according to the note.RBC reiterated its outperform rating on the stock and boosted its price target to $310 from $290.Price: $261.88, Change: $-3.68, Percent Change: -1.38%

$LRCX

Wire63d ago

Agree Realty Outpacing Internal Targets After Strong Start, RBC Says

Agree Realty (ADC) is running ahead of its internal plan across most key metrics, supported by a strong start to the year, RBC Capital Markets said Wednesday in a report.Robust early-year deal flow has the company positioned to reach the high end of its full-year investment plan, the report said. RBC raised its 2026 and 2027 AFFO estimates by $0.02 each, citing better expenses, stronger percentage-rent performance, and a slightly improved cost of capital.Management continues to describe the acquisition environment as highly favorable, with pipelines at record levels and deal activity expected to accelerate through Q3, RBC said. Annual returns on property remain stable, the competitive landscape is steady, and tenant relationships continue to expand, the report said.RBC raised its price target on Agree Realty stock to $82 from $81 and maintained its outperform rating.Price: $76.84, Change: $+0.17, Percent Change: +0.22%

$ADC

Wire63d ago

IonQ Advances Quantum Roadmap, Shift Toward Engineering Execution, Wedbush Says

IonQ (IONQ) is reinforcing a shift toward "engineering execution" in quantum computing following the company's release of a detailed technical blueprint, Wedbush Securities said in a note Thursday.The "engineering roadmap", released Wednesday, details a "concrete" path for scaling "fault-tolerant quantum computing" by integrating hardware, error correction, and modular control systems, the brokerage said.The announcement marks a pivot for the industry, shifting the central question from "if" such powerful machines are possible to "how" and "when" they will be built, according to the note.Historically, skeptics argued that fault tolerance would require "millions of physical qubits," pushing practical use cases decades into the future. However, IonQ's recent milestones, including 99.99% two-qubit fidelity and "reliable ion movement" suggest that timelines are "compressing faster than skeptics assumed," the report added.Industry watchers now believe that what was once considered a "15+ year" outcome for commercial quantum utility could be realized within a few years. This acceleration is expected to have "major implications" for sector valuations, government funding and the pace of enterprise adoption.Wedbush has an outperform rating on IonQ with a price target of $60.Price: $43.90, Change: $-3.46, Percent Change: -7.31%

$IONQ

Wire63d ago

JPMorgan Adjusts Price Target on Robinhood Markets to $92 From $113, Maintains Neutral Rating

Robinhood Markets (HOOD) has an average rating of overweight and mean price target of $104.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $85.85, Change: $-2.59, Percent Change: -2.92%

$HOOD

Wire63d ago

Street Color: Regeneron Pharmaceuticals Reaches Agreement With Trump Administration to Cut Drug Prices, Bloomberg Reports

$REGN

Wire63d ago

Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says

Boston Scientific (BSX) posted Q1 sales and earnings per share beats alongside a "prudent" guidance cut, with Q2 expected to be the trough quarter, RBC Capital Markets said in a note Wednesday.The analysts said management lowered 2026 organic growth outlook to 6.5% to 8% due to "unanticipated headwinds" and "changing business patterns," though many investors already expected a reset, including those who believed the company could make the numbers to reset the base.The analysts called Q1 a "clearing event," with Boston Scientific reporting Electrophysiology growing 21.7% year-over-year on an organic basis versus 18.5% consensus, while Watchman grew 18.8% versus 21.5% consensus, broadly in line with expectations."Looking ahead, we view Q2 as a trough quarter (guided 5% to 7%) with improving growth thereafter aided by new products, improvement in base businesses, and Watchman growth in low double digits. We would be buyers at current valuations," the analysts said.RBC reiterated its outperform rating on Boston Scientific and adjusted its price target to $100 from $105.Price: $65.76, Change: $+0.89, Percent Change: +1.37%

$BSX

Wire63d ago

Wendy's Expected to Face Another Challenging Top-Line Quarter, RBC Capital Markets Says

Wendy's (WEN) is set up for another challenging top-line quarter, with a slight Q1 US same store sales miss, though some directional improvement is anticipated, RBC Capital Markets said in a note Wednesday.The brokerage said Q1 results will reflect whether management's turnaround plan is gaining traction in franchisee locations, as company-operated stores have been outperforming franchisees over the past couple of quarters. The key metric will be franchisee comp relative to company-operated, RBC said.After the company updated its menu in 2025, the brokerage said it is looking for improved consumer value perceptions and higher traffic.Wendy's plans to close 5% to 6% of total US stores, primarily in H1, focusing on its worst performing locations and expecting an impact on its global sales and full-year EBITDA, according to the note.The company's international segment continues to grow, though driven by lower average unit volume markets like Latin America and Asia Pacific, which is dilutive to system sales, while flat population growth in Canada, which contributes about half of international sales, could pose a headwind to same-store-sales growth, the brokerage said.RBC Capital Markets maintained a sector perform rating on Wendy's, with a price target of $8.Shares of Wendy's were down 1.3% in Thursday trading.Price: $7.01, Change: $-0.09, Percent Change: -1.27%

$WEN

Wire63d ago

DigitalBridge Gets Stockholder Approval for Acquisition by SoftBank Group

DigitalBridge Group (DBRG) said Thursday its stockholders voted to approve the acquisition of the company by SoftBank Group at a virtual special meeting of stockholders.As per the acquisition agreement, DigitalBridge stockholders will receive $16 per share in cash upon transaction close, the company said.Approximately 96% of the votes cast favored the acquisition, satisfying the requirement for approval by a majority of shareholders, the company said.The transaction is expected to close in the second half, subject to customary closing conditions and regulatory approvals, according to a statement.Price: $15.62, Change: $+0.01, Percent Change: +0.03%

$DBRG

Wire63d ago

Boeing's Q1 Results Instill More Confidence in 2026 Guidance, RBC Says

Boeing's (BA) Q1 results instill more confidence in the 2026 guidance as the production and delivery rate increases on the 737 MAX and 787 remains on track with little risk linked to the Middle East conflict, RBC Capital Markets said in a Thursday note.The brokerage said it raised its 2026, 2027 and 2028 free cash flow forecast to $3 billion, $7.3 billion and $11 billion, respectively.Defense margins were better than expected in Q1, and the company remains in contention for the F/A-XX opportunity, which would be a positive catalyst, according to the note.Boeing is well positioned in the defense market, with continued de-risking on its development programs a positive, analysts wrote.The brokerage said it reiterated its outperform rating on the stock and price target of $275 per share.Price: $234.03, Change: $+2.75, Percent Change: +1.19%

$BA

Wire63d ago

Market Chatter: Microsoft Plans First Voluntary Employee Buyout Program

Microsoft (MSFT) is planning to offer the first voluntary employee buyout in its history to a small percentage of its workers, CNBC reported Thursday, citing a memo it viewed.The one-time retirement program will be open to US employees at the senior director level and below whose years of employment and age add up to 70 or more, according to the news outlet.Microsoft employees and their managers will get details on May 7, CNBC reported, adding that workers with sales incentive plans will not be able to participate.Microsoft didn't immediately respond to a request for comment by.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $421.31, Change: $-11.61, Percent Change: -2.68%

$MSFT

Wire63d ago

IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says

IMAX (IMAX) will likely benefit from an increase in the volume and quality of filmed-for-IMAX movies in 2026 through 2028, which should boost its market share, Wedbush said in a note Thursday.Meanwhile, the company will also see benefits from a worldwide box office that increasingly mixes local-language and global films, while it is also seeing a greater volume of alternative content to support revenue, and is increasing its global footprint, the note said.The positive factors are likely to help IMAX move beyond 50% earnings before interest, taxes, depreciation, and amortization, or EBITDA, margins by 2028, Wedbush said.This year and next year's "global film slate underscores IMAX's growing prominence in Hollywood and worldwide as an essential partner for major theatrical releases across genres, languages, and geographies," the investment firm said.IMAX is scheduled to report its Q1 financial results on April 30.Wedbush reiterated IMAX's outperform rating and $46 price target.Price: $36.18, Change: $-0.04, Percent Change: -0.11%

$IMAX

Wire63d ago

CME Sees Record Volumes Offset by Pricing Pressure; Data Services Momentum Remains Strong, RBC Says

CME (CME) reported record average daily volumes across all asset classes and regions in Q1, but gains were partially offset by lower revenue per contract, RBC Capital said in a Wednesday note.RBC noted that Market Data and Information Services remains a key strength, with revenue growth accelerating to about 15% year over year, driven by subscriber growth, pricing initiatives, and new product adoption.Management projects revenue growth for 2026 of about 8.5% year over year to roughly $7.07 billion, slightly below consensus estimates of 9.1%, driven by clearing and transaction fees, market data and information services, and other revenues. Adjusted earnings per share is projected at $12.27 versus $12.34 consensus, according to the report.The brokerage expects continued momentum in data services and retail-driven trading activity but flagged tougher year-over-year comparisons in Q2 due to prior-period macro volatility, while maintaining a constructive outlook on CME's structural growth drivers.RBC maintained its sector perform rating on the stock with a price target of $302.Price: $283.06, Change: $-2.65, Percent Change: -0.93%

$CME

Wire63d ago

ServiceNow Stock to Trade Range Bound in the Short-Term, RBC Says

ServiceNow's (NOW) stock is expected to trade range-bound in the short term, driven by organic growth confusion and Iran war uncertainty in a seasonally weak Q1, RBC Capital Markets analysts said in a Thursday note."Against negative software investor sentiment, we thought ServiceNow delivered a solid, but messy Q1 report," RBC said.Analysts said that the company is in a good position to monetize artificial intelligence, consolidate spending, and increase itsguidance as the year progresses.RBC said that ServiceNow's penetration with its current core offerings remains relatively low and that it is well positioned to extend into other areas as well, enabling a high growth rate for many years.Analysts adjusted their 2026 earnings estimate for the company to $4.16 from $4.18. Analysts polled by FactSet expect $4.18.RBC has an outperform rating on the stock and a $121 price target.Price: $85.88, Change: $-17.19, Percent Change: -16.68%

$NOW

Wire63d ago

CME Group Viewed as Strongest Liquidity Venue in Current Market, Morgan Stanley Says

CME Group (CME) is best placed in the current market environment, with recent volatility reducing competitive pressure and pushing traders toward the deepest liquidity pools, Morgan Stanley said Thursday in a report.Debates over inflation and interest rates could lift average daily volume more than 9% in 2026 and 8% in 2027, outpacing the 6% growth seen over the past five years, the report said.CME could also see higher activity as governments run larger deficits, supply chains remain unsettled, and energy markets continue to shift, the report said.Morgan Stanley pointed to rapid growth in CME's event-based contracts, which have drawn 150,000 new accounts and about 215 million trades since their December launch, as well as the exchange's plans to launch 24/7 crypto trading on May 29.9.Still, a softer-than-expected rate per contract in Q1 may weigh on earnings, the report said. Morgan Stanley trimmed its 2027 EPS estimate by 2.5%.Morgan Stanley cut its price target on CME stock to $353 from $362 and maintained its overweight rating.Price: $282.56, Change: $-3.15, Percent Change: -1.10%

$CME

Showing 5721-5740 of 7030

Wire63d ago

Financial News · Live Terminal

Market Chatter: Regeneron Reaches Drug Pricing Deal, Gains US Nod for Rare Deafness Therapy

Rogers Communications' CapEx Cuts to Drive Organic De-levering, RBC Capital Markets Says

IBM Sees 'Solid' Start to 2026 With Q1 Topline Outperformance Coming From Infrastructure, RBC Says

Elevance Health's Tone on 2027 Commercial Pipeline 'Constructive,' RBC Says

Westamerica Bancorporation Ups Quarterly Dividend to $0.48 per Share from $0.46, Payable May 15 to Holders of Record May 4

Lam Research Likely to Benefit from Healthy Wafer Fabrication Equipment Landscape, RBC Says

Agree Realty Outpacing Internal Targets After Strong Start, RBC Says

IonQ Advances Quantum Roadmap, Shift Toward Engineering Execution, Wedbush Says

Top Midday Stories: Tesla Shares Fall Despite Q1 Beats; ServiceNow Says Iran War Weighed on Q1 Subscription Revenue

JPMorgan Adjusts Price Target on Robinhood Markets to $92 From $113, Maintains Neutral Rating

Street Color: Regeneron Pharmaceuticals Reaches Agreement With Trump Administration to Cut Drug Prices, Bloomberg Reports

Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says

Wendy's Expected to Face Another Challenging Top-Line Quarter, RBC Capital Markets Says

DigitalBridge Gets Stockholder Approval for Acquisition by SoftBank Group

Boeing's Q1 Results Instill More Confidence in 2026 Guidance, RBC Says

Market Chatter: Microsoft Plans First Voluntary Employee Buyout Program

IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says

CME Sees Record Volumes Offset by Pricing Pressure; Data Services Momentum Remains Strong, RBC Says

ServiceNow Stock to Trade Range Bound in the Short-Term, RBC Says

CME Group Viewed as Strongest Liquidity Venue in Current Market, Morgan Stanley Says

Market Chatter: Regeneron Reaches Drug Pricing Deal, Gains US Nod for Rare Deafness Therapy

Rogers Communications' CapEx Cuts to Drive Organic De-levering, RBC Capital Markets Says

IBM Sees 'Solid' Start to 2026 With Q1 Topline Outperformance Coming From Infrastructure, RBC Says

Elevance Health's Tone on 2027 Commercial Pipeline 'Constructive,' RBC Says

Westamerica Bancorporation Ups Quarterly Dividend to $0.48 per Share from $0.46, Payable May 15 to Holders of Record May 4

Lam Research Likely to Benefit from Healthy Wafer Fabrication Equipment Landscape, RBC Says

Agree Realty Outpacing Internal Targets After Strong Start, RBC Says

IonQ Advances Quantum Roadmap, Shift Toward Engineering Execution, Wedbush Says

Top Midday Stories: Tesla Shares Fall Despite Q1 Beats; ServiceNow Says Iran War Weighed on Q1 Subscription Revenue

JPMorgan Adjusts Price Target on Robinhood Markets to $92 From $113, Maintains Neutral Rating

Street Color: Regeneron Pharmaceuticals Reaches Agreement With Trump Administration to Cut Drug Prices, Bloomberg Reports

Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says

Wendy's Expected to Face Another Challenging Top-Line Quarter, RBC Capital Markets Says

DigitalBridge Gets Stockholder Approval for Acquisition by SoftBank Group

Boeing's Q1 Results Instill More Confidence in 2026 Guidance, RBC Says

Market Chatter: Microsoft Plans First Voluntary Employee Buyout Program

IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says

CME Sees Record Volumes Offset by Pricing Pressure; Data Services Momentum Remains Strong, RBC Says

ServiceNow Stock to Trade Range Bound in the Short-Term, RBC Says

CME Group Viewed as Strongest Liquidity Venue in Current Market, Morgan Stanley Says